These results were confirmed in a HER2/Neu mouse model of breast cancer, where RICTOR ablation decreased AKT S473 phosphorylation, cellular proliferation and delayed tumor latency, burden and penetrance suggesting that RICTOR promotes the genesis of HER2-overexpressing tumors [31]. The gene discussed is RICTOR; the disease is neoplasm.